C4279981||genome editing
C0022646||renal
C0014597||epithelial cells
C4279981||genome editing technologies
C4279981||targeted introduction
C4279981||alteration
C4279981||removal of genomic sequences
C0025663||methods
C0449475||non-differentiated
C1257912||haploid
C0449475||cell types
C4279981||Genome editing
C0022646||renal
C0014597||epithelial cells
C0033213||technological issues
C4279981||expression of multiple genome editing constructs
C0282574||screening strategies
C4279981||generation of targeted heterozygous and homozygous genomic sequence alterations
C0022646||renal
C0007634||cells
C4277678||transcription activator-like effector nucleases
C4277678||transcription activator-like effector nucleases
C3658200||clustered regularly interspaced short palindromic repeat (CRISPR) system
C0442711||protocols
C2603343||studying
C0085413||autosomal dominant polycystic kidney disease
C0085413||autosomal dominant polycystic kidney disease
C4277689||cell culture-validated genetic modifications
C4042879||mouse embryonic stem cells
C4042879||mouse embryonic stem cells
C0025929||mouse
C0599779||models
C4279981||genome editing
C0449475||cell type
C2603343||study
C0031845||physiological
C0030660||pathophysiological functions
C1516876||engineered genotypes